Skip to main content

Use of intranasal corticosteroids in adenotonsillar hypertrophy

  • E U Sakarya (a1), N Bayar Muluk (a2), E G Sakalar (a3), M Senturk (a1), M Aricigil (a4), S A Bafaqeeh (a5) and C Cingi (a6)...
Abstract Objectives:

This review examined the efficacy of intranasal corticosteroids for improving adenotonsillar hypertrophy.


The related literature was searched using PubMed and Proquest Central databases.


Adenotonsillar hypertrophy causes mouth breathing, nasal congestion, hyponasal speech, snoring, obstructive sleep apnoea, chronic sinusitis and recurrent otitis media. Adenoidal hypertrophy results in the obstruction of nasal passages and Eustachian tubes, and blocks the clearance of nasal mucus. Adenotonsillar hypertrophy and obstructive sleep apnoea are associated with increased expression of various mediators of inflammatory responses in the tonsils, and respond to anti-inflammatory agents such as corticosteroids. Topical nasal steroids most likely affect the anatomical component by decreasing inspiratory upper airway resistance at the nasal, adenoidal or tonsillar levels. Corticosteroids, by their lympholytic or anti-inflammatory effects, might reduce adenotonsillar hypertrophy. Intranasal corticosteroids reduce cellular proliferation and the production of pro-inflammatory cytokines in a tonsil and adenoid mixed-cell culture system.


Intranasal corticosteroids have been used in adenoidal hypertrophy and adenotonsillar hypertrophy patients, decreasing rates of surgery for adenotonsillar hypertrophy.

Corresponding author
Address for correspondence: Dr Nuray Bayar Muluk, Birlik Mahallesi, Zirvekent 2. Etap Sitesi, C-3 blok, No: 6-3/43, 06610 Çankaya, Ankara, Turkey Fax: +90 312 4964073 E-mail:
Hide All
1 Scadding, G. Non-surgical treatment of adenoidal hypertrophy: the role of treating IgE-mediated inflammation. Pediatr Allergy Immunol 2010;21:1095–106
2 Kurnatowski, P, Putyński, L, Łapienis, M, Kowalska, B. Physical and emotional disturbances in children with adenotonsillar hypertrophy. J Laryngol Otol 2008;122:931–5
3 Ray, RM, Bower, CM. Pediatric obstructive sleep apnea: the year in review. Curr Opin Otolaryngol Head Neck Surg 2005;13:360–5
4 Friedman, BC, Hendeles-Amitai, A, Kozminsky, E, Leiberman, A, Friger, M, Tarasiuk, A et al. Adenotonsillectomy improves neurocognitive function in children with obstructive sleep apnea syndrome. Sleep 2003;26:9991005
5 Goldstein, NA, Fatima, M, Campbell, TF, Rosenfeld, RM. Child behavior and quality of life before and after tonsillectomy and adenoidectomy. Arch Otolaryngol Head Neck Surg 2002;128:770–5
6 Kim, J, Bhattacharjee, R, Dayyat, E, Snow, AB, Kheirandish-Gozal, L, Goldman, JL et al. Increased cellular proliferation and inflammatory cytokines in tonsils derived from children with obstructive sleep apnea. Pediatr Res 2009;66:423–8
7 Kheirandish-Gozal, L, Serpero, LD, Dayyat, E, Kim, J, Goldman, JL, Snow, A et al. Corticosteroids suppress in vitro tonsillar proliferation in children with obstructive sleep apnoea. Eur Respir J 2009;33:1077–84
8 Goldbart, AD, Veling, MC, Goldman, JL, Li, RC, Brittian, KR, Gozal, D. Glucocorticoid receptor subunit expression in adenotonsillar tissue of children with obstructive sleep apnea. Pediatr Res 2005;57:232–6
9 Demain, JG, Goetz, DW. Pediatric adenoidal hypertrophy and nasal airway obstruction: reduction with aqueous nasal beclomethasone. Pediatrics 1995;95:355–64
10 Goldbart, AD, Krishna, J, Li, RC, Serpero, LD, Gozal, D. Inflammatory mediators in exhaled breath condensate of children with obstructive sleep apnea syndrome. Chest 2006;130:143–8
11 Goldbart, AD, Tal, A. Inflammation and sleep disordered breathing in children: a state-of-the-art review. Pediatr Pulmonol 2008;43:1151–60
12 Brouillette, RT, Manoukian, JJ, Ducharme, FM, Oudjhane, K, Earle, LG, Ladan, S et al. Efficacy of fluticasone nasal spray for pediatric obstructive sleep apnea. J Pediatr 2001;138:838–44
13 Al-Ghamdi, SA, Manoukian, JJ, Morielli, A, Oudjhane, K, Ducharme, FM, Brouillette, RT. Do systemic corticosteroids effectively treat obstructive sleep apnea secondary to adenotonsillar hypertrophy? Laryngoscope 1997;107:1382–7
14 Alexopoulos, EI, Kaditis, AG, Kalampouka, E, Kostadima, E, Angelopoulos, NV, Mikraki, V et al. Nasal corticosteroids for children with snoring. Pediatr Pulmonol 2004;38:161–7
15 Goldbart, AD, Goldman, JL, Veling, MC, Gozal, D. Leukotriene modifier therapy for mild sleep-disordered breathing in children. Am J Respir Crit Care Med 2005;172:364–70
16 Bhargava, R, Chakravarti, A. A double-blind randomized placebo-controlled trial of topical intranasal mometasone furoate nasal spray in children of adenoidal hypertrophy with otitis media with effusion. Am J Otolaryngol 2014;35:766–70
17 Berlucchi, M, Sessa, M. Can adenoidal hypertrophy be treated with intranasal steroids? Rev Recent Clin Trials 2010;5:123–7
18 Beasley, P. Anatomy of the pharynx and oesophagus. In: Kerr, AG, Gleeson, M, eds. Scott-Brown's Otorhinolaryngology, 6th edn. Oxford: Butterworth-Heinemann Publications, 1997;140
19 Kenna, MA, Amin, A. Anatomy and physiology of the oral cavity. In: Snow, JB, Wackym, PA, eds. Ballenger's Otorhinolaryngology Head and Neck Surgery, 17th edn. Shelton, CT: BC Decker, 2009;769–74
20 Standring, S. Pharynx. In: Standring, S, ed. Gray's Anatomy: The Anatomical Basis of Clinical Practice, 39th edn. Philadelphia: Elsevier/Churchill Livingstone, 2005;619–31
21 Medscape. Tonsil and Adenoid Anatomy. In: [15 March 2016]
22 Wiatrak, BJ, Woolley, AL. Pharyngitis and adenotonsillar disease. In: Cummings, CW, Fredrickson, JM, Harker, LA, Crause, CJ, Schuller, DE, Richardson, MA, eds. Otolaryngology Head and Neck Surgery, 3rd edn. London: Mosby, 1998;188215
23 Çelebi, Ş, Çelik, Ö, Karaca, ÇT, Ulusoy, S. Multiparametric comparison of thermal welding versus cold knife tonsillectomy with tonsil size. J Med Updates 2013;3:1318
24 Hellings, PW, Fokkens, WJ. Allergic rhinitis and its impact on otorhinolaryngology. Allergy 2006;61:656–64
25 Haapaniemi, JJ. Adenoids in school-aged children. J Laryngol Otol 1995;109:196202
26 Huang, SW, Giannoni, C. The risk of adenoid hypertrophy in children with allergic rhinitis. Ann Allergy Asthma Immunol 2001;87:350–5
27 Berlucchi, M, Salsi, D, Valetti, L, Parrinello, G, Nicolai, P. The role of mometasone furoate aqueous nasal spray in the treatment of adenoidal hypertrophy in the pediatric age group: preliminary results of a prospective, randomized study. Pediatrics 2007;119:e13927
28 Kveton, JF, Pillsbury, HC 3rd, Sasaki, CT. Nasal obstruction: adenoiditis vs adenoid hypertrophy. Arch Otolaryngol 1982;108:315–18
29 Papatziamos, G, Van Der Ploeg, I, Hemlin, C, Patwardhan, A, Scheynius, A. Increased occurrence of IgE+ and FcεRI+ cells in adenoids from atopic children. Allergy 1999;54:916–25
30 Fokkens, WJ, Vinke, JG, De Jong, SS, Bogaert, DP, Kleinjan, A, Eichhorn, E. Differences in cellular infiltrates in the adenoid of allergic children compared with age- and gender-matched controls. Clin Exp Allergy 1998;28:187–95
31 Nguyen, LH, Manoukian, JJ, Sobol, SE, Tewfik, TL, Mazer, BD, Schloss, MD et al. Similar allergic inflammation in the middle ear and the upper airway: evidence linking otitis media with effusion to the united airways concept. J Allergy Clin Immunol 2004;114:1110–15
32 Goldbart, AD, Veling, MC, Goldman, JL, Li, RC, Brittian, KR, Gozal, D. Glucocorticoid receptor subunit expression in adenotonsillar tissue of children with obstructive sleep apnea. Pediatr Res 2005;57:232–6
33 Mabry, RL. Corticosteroids in the management of upper respiratory allergy: the emerging role of steroid nasal sprays. Otolaryngol Head Neck Surg 1992;107:855–60
34 Fraunfelder, FT, Meyer, SM. Posterior subcapsular cataracts associated with nasal or inhalation corticosteroids. Am J Ophthalmol 1990;109:489–90
35 Oztürk, F, Yücetürk, AV, Kurt, E, Unlü, HH, Ilker, SS. Evaluation of intraocular pressure and cataract formation following the long-term use of nasal corticosteroids. Ear Nose Throat J 1998;77:846–8, 850–1
36 Check, WA, Kaliner, MA. Pharmacology and pharmacokinetics of topical corticosteroid derivatives used for asthma therapy. Am Rev Respir Dis 1990;141:S4451
37 Ryrfeldt, A, Andersson, P, Edsbäcker, S, Tönnesson, M, Davies, D, Pauwels, R. Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid. Eur J Respir Dis 1982;122:8695
38 Wallace, DV, Dykewicz, MS, Bernstein, DI, Blessing-Moore, J, Cox, L, Khan, DA et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008;122(2 suppl):S184
39 Zitt, M, Kosoglou, T, Hubbell, J. Mometasone furoate nasal spray: a review of safety and systemic effects. Drug Saf 2007;30:317–26
40 Medscape. Nasal Polyps Treatment & Management. In: [15 March 2016]
41 Ferguson, AC, Spier, S, Manjra, A, Versteegh, FG, Mark, S, Zhang, P. Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide. J Pediatr 1999;134:422–7
42 Lipworth, BJ. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med 1999;159:941–55
43 Barnes, PJ, Pedersen, S. Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992. Am Rev Respir Dis 1993;148:S126
44 Lane, JC, Dworkin-Valenti, J, Chiodo, L, Haupert, M. Postoperative tonsillectomy bleeding complications in children: a comparison of three surgical techniques. Int J Pediatr Otorhinolaryngol 2016;88:184–8
45 Jones, DT, Kenna, MA, Guidi, J, Huang, L, Johnston, PR, Licameli, GR. Comparison of postoperative pain in pediatric patients undergoing coblation tonsillectomy versus cautery tonsillectomy. Otolaryngol Head Neck Surg 2011;144:972–7
46 Gallagher, TQ, Wilcox, L, McGuire, E, Derkay, CS. Analyzing factors associated with major complications after adenotonsillectomy in 4776 patients: comparing three tonsillectomy techniques. Otolaryngol Head Neck Surg 2010;142:886–92
47 Divi, V, Benninger, M. Postoperative tonsillectomy bleed: coblation versus noncoblation. Laryngoscope 2005;115:31–3
48 Setabutr, D, Adil, EA, Adil, TK, Carr, MM. Emerging trends in tonsillectomy. Otolaryngol Head Neck Surg 2011;145:223–9
49 Rakover, Y, Almog, R, Rosen, G. The risk of postoperative haemorrhage in tonsillectomy as an outpatient procedure in children. Int J Pediatr Otorhinolaryngol 1997;41:2936
50 Randall, DA, Hoffer, ME. Complications of tonsillectomy and adenoidectomy. Otolaryngol Head Neck Surg 1998;118:61–8
51 Medscape. Tonsillectomy Treatment & Management. In: [19 October 2016]
52 Leinbach, RF, Markwell, SJ, Colliver, JA, Lin, SY. Hot versus cold tonsillectomy: a systematic review of the literature. Otolaryngol Head Neck Surg 2003;129:360–4
53 Tonsillectomy (with or without adenoidectomy) in children: postoperative care and complications. In: [9 June 2016]
54 Royal Australasian College of Physicians and Australian Society of Otolaryngology Head and Neck Surgery. A Joint Position Paper of the Paediatrics & Child Health Division of The Royal Australasian College of Physicians and The Australian Society of Otolaryngology, Head and Neck Surgery. Sydney: Royal Australasian College of Physicians and Australian Society of Otolaryngology Head and Neck Surgery, 2008
55 Royal College of Surgeons of England. National Prospective Tonsillectomy Audit. Final Report of an Audit carried out in England and Northern Ireland between July 2003 and September 2004. London: Royal College of Surgeons of England, 2005
56 Edmonson, MB, Eickhoff, JC, Zhang, C. A population-based study of acute care revisits following tonsillectomy. J Pediatr 2015;166:607–12
57 Shay, S, Shapiro, NL, Bhattacharyya, N. Revisit rates and diagnoses following pediatric tonsillectomy in a large multistate population. Laryngoscope 2015;125:457–61
58 Curtis, JL, Harvey, DB, Willie, S, Narasimhan, E, Andrews, S, Henrichsen, J et al. Causes and costs for ED visits after pediatric adenotonsillectomy. Otolaryngol Head Neck Surg 2015;152:691–6
59 Jonas, NE, Sayed, R, Prescott, CA. Prospective, randomized, single-blind, controlled study to compare two methods of performing adenoidectomy. Int J Pediatr Otorhinolaryngol 2007;71:1555–62
60 Yumoto, E, Kozawa, T, Yanagihara, N. Influence of tonsillar hypertrophy to physical growth and diseases of the nose and ear in school-age children [in Japanese]. Nihon Jibiinkoka Gakkai Kaiho 1991;94:534–40
61 Mansfield, LE, Diaz, G, Posey, CR, Flores-Neder, J. Sleep disordered breathing and daytime quality of life in children with allergic rhinitis during treatment with intranasal budesonide. Ann Allergy Asthma Immunol 2004;92:240–4
62 Modrzynski, M, Zawisza, E. An analysis of the incidence of adenoid hypertrophy in allergic children. Int J Pediatr Otorhinolaryngol 2007;71:713–19
63 Modrzyński, M, Zawisza, E, Mazurek, H. The influence of medical treatment of the perennial allergic rhinitis on the adenoid size in children [in Polish]. Otolaryngol Pol 2006;60:543–50
64 Zhang, L, Mendoza-Sassi, RA, César, JA, Chadha, NK. Intranasal corticosteroids for nasal airway obstruction in children with moderate to severe adenoidal hypertrophy. Cochrane Database Syst Rev 2008;(16):CD006286
65 Ciprandi, G, Varricchio, A, Capasso, M, Varricchio, AM, De, LA, Ascione, E et al. Intranasal flunisolide treatment in children with adenoidal hypertrophy. Int J Immunopathol Pharmacol 2007;20:833–6
66 Varricchio, A, Tortoriello, G, Capasso, M, De, LA, Marchisio, P, Varricchio, AM et al. Prevention of surgery in children with adenoidal hypertrophy treated with intranasal flunisolide: a 12-month follow-up. J Biol Regul Homeost Agents 2009;23:95101
67 Jazi, SM, Barati, B, Kheradmand, A. Treatment of adenotonsillar hypertrophy: a prospective randomized trial comparing azithromycin vs. fluticasone. J Res Med Sci 2011;16:1590–7
68 Brouillette, RT, Manoukian, JJ, Ducharme, FM, Oudjhane, K, Earle, LG, Ladan, S et al. Efficacy of fluticasone nasal spray for pediatric obstructive sleep apnea. J Pediatr 2001;138:838–44
69 Kheirandish-Gozal, L, Gozal, D. Intranasal budesonide treatment for children with mild obstructive sleep apnea syndrome. Pediatrics 2008;122:e14955
70 Criscuoli, G, D'Amora, S, Ripa, G, Cinquegrana, G, Mansi, N, Impagliazzo, N et al. Frequency of surgery among children who have adenotonsillar hypertrophy and improve after treatment with nasal beclomethasone. Pediatrics 2003;111:e2368
71 Kuyucu, S, Kuyuucu, N, Unal, S, Apaydın, D. Nonsurgical treatment of adenoidal hypertrophy with cefuroxime axetil and intranasal mometasone furoate combination. J Pediatr Inf 2007;1:612
72 Mygind, N, Nielsen, LP, Hoffmann, HJ, Shukla, A, Blumberga, G, Dahl, R et al. Mode of action of intranasal corticosteroids. J Allergy Immunol 2001;108:S1625
73 Brodsky, L, Moore, L, Stanievich, JF, Ogra, PL. The immunology of tonsils in children: the effect of bacterial load on the presence of B- and T-cell subsets. Laryngoscope 1988;98:93–8
74 Stanbury, RM, Graham, EM. Systemic corticosteroid therapy--side effects and their management. Br J Ophthalmol 1998;82:704–8
75 Allen, DB. Systemic effects of intranasal steroids: an endocrinologist's perspective. J Allergy Clin Immunol 2000;106:S17990
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The Journal of Laryngology & Otology
  • ISSN: 0022-2151
  • EISSN: 1748-5460
  • URL: /core/journals/journal-of-laryngology-and-otology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Altmetric attention score

Full text views

Total number of HTML views: 14
Total number of PDF views: 148 *
Loading metrics...

Abstract views

Total abstract views: 954 *
Loading metrics...

* Views captured on Cambridge Core between 27th February 2017 - 17th March 2018. This data will be updated every 24 hours.